IXONOS: DISCLOSURE NOTIFICATION UNDER CHAPTER 9, SECTION 5

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
IXONOS: DISCLOSURE NOTIFICATION UNDER CHAPTER 9, SECTION 5 OF THE SECURITIES MARKETS ACT AND PERMANENT EXEMPTION FROM THE OBLIGATION TO MAKE A MANDATORY PUBLIC TENDER OFFER UNDER CHAPTER 11, SECTION 26 OF THE SECURITIES MARKET ACT

Helsinki, Finland, 2013-11-14 17:33 CET (GLOBE NEWSWIRE) -- Ixonos Plc          Stock Exchange Release          14 November 2013 at 18:30  

On 14 November 2013, Ixonos Plc ("Ixonos" or "Company") has received the following disclosure notification, pursuant to the Securities Markets Act, of a potential change in a portion of holdings:

Turret Oy Ab's ("Turret") portion of Ixonos' voting rights and total number of shares may exceed 30 or 50 per cent should Turret subscribe all shares to which its subscription commitment in Ixonos' rights issue ("Rights Issue"), announced on 11 November 2013, applies. On 11 November 2013, Turret held altogether 1,708,884 Ixonos shares, which is equivalent to approximately 24.25 per cent of Ixonos' share capital and voting rights.

The Finnish Financial Supervisory Authority has today granted a permanent exemption under Chapter 11, Section 26 of the Securities Market Act to Turret from the obligation to make a mandatory public tender offer for the remaining shares in Ixonos and securities issued by the Company entitling to shares in the Company pursuant to Chapter 11, Section 19 of the Securities Market Act in the event that Turret's shareholding would, based on the subscription commitment, corresponding to Turret’s pro rata ownership in the Company, exceed 30 or 50 per cent of the votes in the Company as a result of the Rights Issue.

In addition to Turret, the Chairman of the Company’s Board, Mr Pertti Ervi (approximately 0.35 per cent of shares) and the Company’s CEO, Mr Esa Harju (approximately 0.17 per cent of shares), both shareholders in the Company, have given a subscription commitment to fully subscribe all new shares that may be subscribed pursuant to their holdings in the Company. Should Turret and the other aforementioned parties that have given a subscription commitment be the only parties to subscribe the new shares offered in the Rights Issue, Turret’s maximum ownership share in Ixonos would be 20,506,608 shares following the Rights Issue, which would be equivalent to approximately 78.13 per cent of Ixonos’ share capital and voting rights.

In addition to its subscription commitment, Turret has provided an underwriting commitment to subscribe shares that are otherwise not subscribed in the Rights Issue with a maximum amount of EUR 1 million. If the underwriting commitment provided by Turret is used, it shall, however, only be used to the extent that Turret’s ownership does not exceed 30 per cent of all voting rights attached to the Company’s shares as a result of the use of the subscription commitment and underwriting commitment. The subscription commitment and the underwriting commitment may only be used if certain standard preconditions are met.

Before the Rights Issue, Ixonos has altogether 7,047,825 shares and votes. If the Rights Issue is fully subscribed, Ixonos will have altogether 84,573,900 shares and votes.

Helsinki, 14 November 2013

IXONOS PLC

The Board of Directors

Additional Information

Esa Harju, CEO and President, tel. +358 40 844 3367, esa.harju@ixonos.com

Teppo Talvinko, CFO, puh. +358 40 7153 660, teppo.talvinko@ixonos.com

Distribution:

NASDAQ OMX Helsinki

Main media

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 8

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 10

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 5

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 5

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 4

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 4

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 5

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Rise and Fall of MedMen's Cannabis Empire

Updated Category News Views 178

Let's slice through the smoke and mirrors of MedMen's saga—a story that captures the dizzying heights and staggering lows of what was once the poster child for America's cannabis gold rush. The buzz is about a documentary from Bungalow Media + Entertainment that’s gearing up to pull back the curtain on Adam Bierman and his rollercoaster ride with MedMen. They kicked...

Continue Reading
Draganfly Secures $25 Million for Innovative Drone Solutions

Updated Category News Views 136

Overview of Recent Financial Activities Draganfly Inc. (NASDAQ: DPRO), a leader in drone technology and robotics, has made significant strides in its financial landscape by securing a registered direct offering. This initiative is designed to enhance their operational capabilities and support new product developments. Details of the Direct Offering In a recent...

Continue Reading
Current Sentiment Analysis: Canaan Inc's Short Interest Insights

Updated Category News Views 304

Canaan Inc's Current Short Interest Overview Canaan Inc (NYSE: CAN) is witnessing changes in its stock sentiment, particularly regarding its short interest. Recent reports indicate that the short interest, expressed as a percentage of the float, has dropped by 8.14%. Currently, 36.17 million shares are sold short, representing 8.58% of the total shares available for...

Continue Reading
iHerb's Chief Operating Officer Miriee Chang Set to Retire

Updated Category News Views 196

iHerb Announces Retirement of COO Miriee Chang iHerb, a global leader in online retail for wellness products, has announced the planned retirement of Chief Operating Officer Miriee Chang. This change marks a significant transition for the company, dedicated to maintaining its operational excellence and customer service quality. Continuity During the Transition Miriee...

Continue Reading
Liberty Broadband to Reveal Q4 2024 Performance in Upcoming Call

Updated Category News Views 103

Liberty Broadband Corporation's Upcoming Conference Call Liberty Broadband Corporation (Nasdaq: LBRDA, LBRDK, LBRDP) is gearing up for a significant event as it prepares to hold a conference call to unveil its financial results for the fourth quarter of 2024. This highly anticipated call is set to take place soon, providing an opportunity for stakeholders and interested...

Continue Reading